{
    "title": "U.S. FDA panel votes against Spectrum's lung cancer drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11240199/U-S-FDA-panel-votes-against-Spectrums-lung-cancer-drug.html",
    "date": "2022-09-22",
    "keywords": [
        "drug",
        "cancer",
        "lung",
        "treatment",
        "cell",
        "efficacy",
        "decision",
        "panel",
        "poziotinib",
        "regulator",
        "fda",
        "date",
        "mutation",
        "food",
        "administration",
        "form",
        "nonsmall",
        "level",
        "lack",
        "optimization",
        "tuesday",
        "daiichi",
        "sankyos",
        "astrazenecas",
        "enhertu",
        "delay",
        "confirmation",
        "benefit",
        "approval",
        "therapy",
        "unmet",
        "need",
        "activity",
        "dont",
        "improvement",
        "world",
        "scott",
        "waldman",
        "chair",
        "department",
        "pharmacology",
        "physiology",
        "amp",
        "biology",
        "thomas",
        "jefferson",
        "university",
        "advise",
        "executive",
        "officer",
        "tom",
        "riga",
        "statement",
        "disappointment",
        "outcome",
        "company",
        "program",
        "nsclc",
        "disease",
        "reporting",
        "khushi",
        "mandowara",
        "roy",
        "kuber"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}